- Home
- LUCD vs KALA Comparison
LUCD vs KALA Comparison
Compare LUCD & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- KALA
- Stock Information
- Founded
- LUCD 2018
- KALA 2009
- Country
- LUCD United States
- KALA United States
- Employees
- LUCD 70
- KALA N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- LUCD Health Care
- KALA Health Care
- Exchange
- LUCD Nasdaq
- KALA Nasdaq
- Market Cap
- LUCD 135.6M
- KALA N/A
- IPO Year
- LUCD 2021
- KALA 2017
- Fundamental
- Price
- LUCD $1.15
- KALA $3.36
- Analyst Decision
- LUCD Strong Buy
- KALA Strong Buy
- Analyst Count
- LUCD 4
- KALA 2
- Target Price
- LUCD $3.88
- KALA $15.00
- AVG Volume (30 Days)
- LUCD 1.3M
- KALA 95.7K
- Earning Date
- LUCD 05-14-2025
- KALA 05-13-2025
- Dividend Yield
- LUCD N/A
- KALA N/A
- EPS Growth
- LUCD N/A
- KALA N/A
- EPS
- LUCD N/A
- KALA N/A
- Revenue
- LUCD $4,346,000.00
- KALA N/A
- Revenue This Year
- LUCD $107.75
- KALA N/A
- Revenue Next Year
- LUCD $231.37
- KALA N/A
- P/E Ratio
- LUCD N/A
- KALA N/A
- Revenue Growth
- LUCD 79.00
- KALA N/A
- 52 Week Low
- LUCD $0.63
- KALA $2.92
- 52 Week High
- LUCD $1.80
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- LUCD 41.93
- KALA 40.99
- Support Level
- LUCD $1.19
- KALA $3.15
- Resistance Level
- LUCD $1.24
- KALA $5.03
- Average True Range (ATR)
- LUCD 0.07
- KALA 0.44
- MACD
- LUCD -0.00
- KALA 0.12
- Stochastic Oscillator
- LUCD 15.79
- KALA 29.86
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.